Drugmaker Wyeth is suing the Food and Drug Administration to block the sale of a generic rival to its intravenous antibiotic Zosyn, claiming the generic is not an equivalent product and could harm critically ill patients.
Wyeth sues FDA to block rival generic antibioticCourtesy Newsvine - business Wed, 09/23/2009 - 07:52
Drugmaker Wyeth is suing the Food and Drug Administration to block the sale of a generic rival to its intravenous antibiotic Zosyn, claiming the generic is not an equivalent product and could harm critically ill patients. Related itemsAP Enterprise: FDA helps states get execution drug
FDA prepares to reassess much-debated knee implant
FDA device chief resigns following complaints
Samsung SCX-4200 3-in-1 True Multifunction Printer
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
|
Popular by tags WeekMonth |
Post new comment